The invention relates to a traditional
Chinese drug composition for treating
carotid atherosclerosis plaque. The traditional
Chinese drug composition comprises the following raw materials, wherein the raw materials comprise, by weight, 30-60 parts of mongolian
milkvetch root, 12-26 parts of dangshen, 12-24 parts of angelica, 10-18 parts of szechwan lovage
rhizome, 16-30 parts of
rehmannia dride
rhizome, 12-30 parts of dan-shen root, 12-18 parts of safflower, 20-60 parts of peach seed and 12-40 parts of lobed kudzuvine root. The traditional
Chinese drug composition has advantages of scientific and reasonable formula, definite
therapeutic effect, easy taking, and definite anti-
arteriosclerosis therapeutic effect. With the traditional Chinese
drug composition, the atherosclerotic plaque can be effectively eliminated so as to reduce the incidence and the re-admission rate of cardio-cerebrovascular important events. All the components of the traditional Chinese
drug composition are the pure traditional Chinese drugs, no significant adverse reaction is generated, the safety is high, and the
patient compliance is good. Compared to other drugs for treating the atherosclerosis, the traditional Chinese
drug composition of the present invention has the following advantages that: the price is low, the traditional Chinese drug composition is easy to widely use in the
community hospitals and the primary hospitals, such that the economic burden of the patient family and the society can be reduced, and the practicality is provided in the drug economics field.